Grace Therapeutics, Inc. 10-K

Filed 2021-06-22 · Original on SEC.gov

Attached exhibits

EX-10.2 · Material contract EX-10.3 · Material contract EX-10.6 · Material contract EX-23.1 · Auditor consent

Item 3. Legal Proceedings

Item 3. 
 Legal Proceedings 

 Due to the fact that a portion of our intellectual property rights are
licensed to us by Neptune/Aker, we rely on Neptune/Aker to protect a certain of the intellectual property rights that we use under our
license agreement with Neptune/Aker. Neptune/Aker are engaged in a number of legal actions related to their intellectual property.

 Item 4. 
 Mine Safety Disclosures 

 Not applicable.

 PART II

Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.